The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival
- 27 February 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical & Experimental Metastasis
- Vol. 25 (4), 357-369
- https://doi.org/10.1007/s10585-008-9146-6
Abstract
Microarray expression signature analyses have suggested that extracellular matrix (ECM) gene dysregulation is predictive of metastasis in both mouse mammary tumorigenesis and human breast cancer. We have previously demonstrated that such ECM dysregulation is influenced by hereditary germline-encoded variation. To identify novel metastasis efficiency modifiers, we performed expression QTL (eQTL) mapping in recombinant inbred mice by characterizing genetic loci modulating metastasis-predictive ECM gene expression. Three reproducible eQTLs were observed on chromosomes 7, 17 and 18. Candidate genes were identified by correlation analyses and known associations with metastasis. Seven candidates were identified (Ndn, Pi16, Luc7l, Rrp1b, Brd4, Centd3 and Csf1r). Stable transfection of the highly metastatic Mvt-1 mouse mammary tumor cell line with expression vectors encoding each candidate modulated metastasis-predictive ECM gene expression. Implantation of these cells into mice demonstrated that candidate gene ectopic expression impacts tumor progression. Gene expression analyses facilitated the construction of a transcriptional network that we have termed the ‘Diasporin Pathway’. This pathway contains the seven candidates, as well as metastasis-predictive ECM genes and metastasis suppressors. Brd4 and Rrp1b appear to form a central node within this network, which likely is a consequence of their physical interaction with the metastasis efficiency modifier Sipa1. Furthermore, we demonstrate that the microarray gene expression signatures induced by activation of ECM eQTL genes in the Mvt-1 cell line can be used to accurately predict survival in a human breast cancer cohort. These data imply that the Diasporin Pathway may be an important nexus in tumor progression in both mice and humans.Keywords
This publication has 42 references indexed in Scilit:
- Rrp1b, a New Candidate Susceptibility Gene for Breast Cancer Progression and MetastasisPLoS Genetics, 2007
- Rap1 Integrates Tissue Polarity, Lumen Formation, and Tumorigenic Potential in Human Breast Epithelial CellsCancer Research, 2007
- Rap1: A turnabout for the crosstalk between cadherins and integrinsEuropean Journal of Cell Biology, 2006
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005
- Metastasis Predictive Signature Profiles Pre-exist in Normal TissuesClinical & Experimental Metastasis, 2005
- An integrative genomics approach to infer causal associations between gene expression and diseaseNature Genetics, 2005
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerThe New England Journal of Medicine, 2002
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- A novel brain-specific mRNA encoding nuclear protein (necdin) expressed in neurally differentiated embryonal carcinoma cellsBiochemical and Biophysical Research Communications, 1991